All Stories

  1. Is There Any Significant Difference in Stent Thrombosis Between Sirolimus and Paclitaxel Eluting Stents?
  2. CABG and PCI in insulin-treated T2DM
  3. Impact of Modifiable Cardiovascular Risk Factors on Mortality After Percutaneous Coronary Intervention
  4. Obesity Paradox after Cardiovascular Intervention
  5. DAPT and TAPT in T2DM after PCI
  6. Adverse cardiovascular outcomes between insulin-treated and non-insulin treated T2DM after PCI